-
Featured Authors
Archive
- May 2013 (1)
- April 2013 (4)
- March 2013 (3)
- February 2013 (1)
- January 2013 (1)
- October 2012 (2)
- September 2012 (1)
- August 2012 (3)
- June 2012 (4)
- May 2012 (4)
- April 2012 (2)
- March 2012 (2)
- February 2012 (1)
- December 2011 (2)
- October 2011 (3)
- September 2011 (2)
- August 2011 (1)
- July 2011 (1)
- June 2011 (4)
- May 2011 (5)
- April 2011 (4)
- March 2011 (2)
- December 2010 (1)
- September 2010 (1)
- April 2010 (5)
- March 2010 (6)
- February 2010 (1)
- January 2010 (2)
Category Archives: The One-on-One Compass
BIO Investor Forum Company Snapshot: Syndax Pharmaceuticals
Next up in our Company Snapshot segment for the BIO Investor Forum is another presenting company of the event. Hear from Joanna Horobin, President & CEO of Syndax Pharmaceuticals, Inc. Company Snapshot What are the short-term and long-term priorities for your company? Near-term we are focused on moving our lead product candidate, entinostat, in to a phase 3 clinical trial for post-menopausal women with estrogen receptor-positive (ER+) metastatic breast cancer (MBC). Long-term our goal is Read More >
BIO Investor Forum Company Snapshot: GlobeImmune, Inc.
The BIO Investor Forum will be here before we know it, and we wanted to take the opportunity to highlight some of the companies who will be presenting at the 10th anniversary event. In our first Company Snapshot, hear from Timothy C. Rodell, the President and Chief Executive Officer of GlobeImmune, Inc. Company Snapshot Q: What are the short-term and long-term priorities for your company? Short term – in oncology, completing the GI-4000 phase Read More >
